Yongfeng Wu

Chinese Academy of Medical Sciences & Peking Union Medical College — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

11h-index938citations18works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(4), Cancer Immunotherapy and Biomarkers(3), RNA modifications and cancer(3), Circular RNAs in diseases(3), Head and Neck Cancer Studies(2)

Publications18 total

Identification of metastasis-related long non-coding RNAs in lung cancer through a novel tumor mesenchymal score
Pathology - Research and Practice·2022· 4 cited
Safety of Neoadjuvant Immunotherapy in Resectable Cancers: A Meta-Analysis
Frontiers in Immunology·2022· 6 citedOpen Access
Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis
Pathology - Research and Practice·2021· 25 cited
Association between vitamin D/calcium intake and 25-hydroxyvitamin D and risk of ovarian cancer: a dose-response relationship meta-analysis
European Journal of Clinical Nutrition·2020· 21 cited
The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients’ age
Biomarker Research·2020· 41 citedOpen Access
Benzo(a)pyrene regulated A549 cell migration, invasion and epithelial-mesenchymal transition by up-regulating long non-coding RNA linc00673
Toxicology Letters·2019· 34 cited
The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis
Frontiers in Oncology·2019· 141 citedOpen Access
Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists
Current Molecular Pharmacology·2018· 11 cited
Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
Cancers·2018· 52 citedOpen Access
Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
Oncology Letters·2018· 30 citedOpen Access
Erratum to: Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p
Molecular Cancer·2017· 220 citedOpen Access
Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p
Molecular Cancer·2017· 305 citedOpen Access
An Ensemble Approach for Record Matching in Data Linkage
Studies in health technology and informatics·2016
CBP/catenin antagonist safely eliminates drug-resistant leukemia-initiating cells
Oncogene·2015· 47 citedOpen Access
[Analysis of chromosome regions 8q11.1-q13.3, 1q32-q34.3 and 14q31.1-q13.3 in a Chinese family with congenital preauricular fistula].
PubMed·2015
Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?
Journal of cancer research updates·2013· 1 citedOpen Access
Short-term effects of induction chemotherapy with one cycle TPF regimen in the N advanced local nasopharyngeal carcinoma
肿瘤研究与临床·2010
Significance of serum endostatin levels in patients with lung cancer
Journal of Clinical Pulmonary Medicine·2009

Frequent Co-authors

Dajing Xia(7), Yuequn Niu(5), Jinming Xu(5), Honghe Zhang(4), Jian Hu(4), Yihua Wu(3), Yihua Wu(3), Yi Zhao(3), Michaël Kahn(3), Jiawei Xu(3), Kelie Chen(3), Wei Lu(2), Wenjie Sun(2), Hongyi Li(2), Jianlu Kong(2), Kefeng Ding(2), Han‐Ming Shen(2), Han Wu(2), Wang Lv(2), Kaijin Wu(2)